Concomitant medical products: 5076-58 lead; 5076-52 lead; 429888 lead implanted: (b)(6) 2018.This device was reported as included in the field action.Based on the information received and without the return of the product, it cannot be confirmed that this device performed as described in the field action.It is included in the field action in the abundance of caution.If information is provided in the future, a supplemental report will be issued.
|
It was reported that one day post cardiac resynchronization therapy pacemaker (crt-p) implant, the patient had a large pericardial effusion.An emergent pericardiocentesis was performed, which resolved the issue.It was further reported that post-operatively, the patient had some hypotension, anemia, thrombocytopenia, swelling/redness and pain in the left arm due to deep vein thrombosis.Medication was administered, and the device remains in use.The patient is a participant in the adaptresponse clinical study.No further patient complications have been reported as a result of this event.
|